{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Louisville",
      "state": "KY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "82660",
      "recalling_firm": "US Worldmeds LLC",
      "address_1": "4441 Springdale Rd",
      "address_2": "N/A",
      "postal_code": "40241-1086",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-1275-2019",
      "product_description": "Revonto (dantrolene sodium for injection), 20 mg/vial, For treatment of malignant hyperthermia, For Intravenous Use Only, Rx Only, Made in Italy, Dist. by:  US WorldMeds, LLC, Louisville, KY 40241, NDC: 27505-003-67",
      "product_quantity": "6456 vials",
      "reason_for_recall": "Presence of Precipitate: Appearance is Out of Specification for the reconstituted solution during 24-month stability time point analysis.",
      "recall_initiation_date": "20190425",
      "center_classification_date": "20190510",
      "termination_date": "20220917",
      "report_date": "20190508",
      "code_info": "Lot: 17REV01, Exp. 12/2019"
    }
  ]
}